학술논문
Safety of switching from intravenous to subcutaneous rituximab during first-line treatment of patients with non-Hodgkin lymphoma: the Spanish population of the MabRella study
Document Type
Article
Author
Source
In: British Journal of Haematology . (British Journal of Haematology, 1 March 2020, 188(5):661-673)
Subject
Language
English
ISSN
13652141
00071048
00071048